Circulating Small Noncoding RNA Biomarkers of Response to Triple Disease-modifying Antirheumatic Drug Therapy in White Women With Early Rheumatoid Arthritis.
Andrew D FoersAlexandra L GarnhamAaron T L LunSusanna M ProudmanLesley ChengAndrew F HillKen C PangIan P WicksPublished in: The Journal of rheumatology (2020)
Pretreatment levels of specific serum sncRNA might facilitate identification of patients more likely to respond to triple DMARD therapy.